US health officials move to let pharmacies make peptides
Federal health officials are advancing a plan that would let specialty pharmacies produce certain peptides, a loosely regulated class of injections.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Federal health officials are advancing a plan that would let specialty pharmacies produce certain peptides, a loosely regulated class of injections. Health Secretary Robert F. Kennedy Jr. favors the plan, and a report says he has proposed that the FDA look the other way on unproven peptides. FDA scientists said none of the popular peptide drugs have been shown to be safe or effective.
Why it matters
The plan would widen access to peptide drugs that FDA scientists say have not been proven safe or effective.
Timeline
- Oct 15, 4:46 PM ET: U.S. health officials moved ahead with a plan to let specialty pharmacies produce certain peptides.
- Oct 16, 1:05 PM ET: A report said Kennedy proposed that the FDA look the other way on unproven peptides, and FDA scientists said none of the popular drugs had been proven safe or effective.
Coverage
- RFK Jr. proposes FDA look the other way on unproven peptides, report says (arstechnica.com)
- Trump administration advances plan for peptide drugs favored by RFK Jr. (AP)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials